ASCLF (Ascletis Pharma) 3-Year Book Growth Rate : -8.50% (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Ascletis Pharma 3-Year Book Growth Rate?

Ascletis Pharma's Book Value per Share for the quarter that ended in Jun. 2024 was $0.30.

During the past 12 months, Ascletis Pharma's average Book Value per Share Growth Rate was -10.80% per year. During the past 3 years, the average Book Value per Share Growth Rate was -8.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was -7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 8 years, the highest 3-Year average Book Value per Share Growth Rate of Ascletis Pharma was 130.80% per year. The lowest was -8.50% per year. And the median was -4.20% per year.

Competitive Comparison of Ascletis Pharma's 3-Year Book Growth Rate

For the Biotechnology subindustry, Ascletis Pharma's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascletis Pharma's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascletis Pharma's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Ascletis Pharma's 3-Year Book Growth Rate falls into.

Ascletis Pharma 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Ascletis Pharma (OTCPK:ASCLF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Ascletis Pharma 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Ascletis Pharma's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascletis Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascletis Pharma Inc (OTCPK:ASCLF) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

01672:Hong Kong 2VJ:Germany

Address

198 Qidi Road, 12th Floor, Building D, HIPARK, Xiaoshan District, Zhejiang Province, Hangzhou, CHN, 311200

Website

https://www.ascletis.com

Ascletis Pharma Inc is an investment holding company. Along with its subsidiaries, it is engaged in the research and development, production, marketing, and sale of pharmaceutical products. It has three marketed products, i.e. Ritonavir tablets, GANOVO, and ASCLEVIR. It also has other drug candidates in its pipeline in their different stages of development such as ASC22, ASC10, ASC11, and ASC40 among others. Geographically, it operates in Mainland China and other countries.